✦ LIBER ✦

Recurrent autoimmune hepatitis after liver transplantation: A disease continuum or a fresh start?

✍ Scribed by Albert J. Czaja

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 62 KB
Volume: 15
Category: Article
ISSN: 1527-6465
DOI: 10.1002/lt.21809

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Recurrence of autoimmune liver disease a

Recurrence of autoimmune liver disease after liver transplantation: A systematic review

✍ Manjushree Gautam; Rekha Cheruvattath; Vijayan Balan 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 237 KB

Recurrence of autoimmune liver disease in allografts has long been a topic of debate. We conducted a systematic review of the literature to examine the reported incidence of recurrence after liver transplantation of primary biliary cirrhosis (PBC), primary sclerosing cholangitis (PSC), and autoimmun

Recurrence of autoimmune disease, primar

Recurrence of autoimmune disease, primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis after liver transplantation

✍ Jean-Charles Duclos-Vallee; Mylène Sebagh 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 424 KB 👁 1 views

1. Recurrence of primary sclerosing cholangitis. a Five percent of liver transplants are performed because of end-stage liver disease secondary to primary sclerosing cholangitis. b Recurrent disease affects 10% to 27% of recipients. c Diagnostic criteria of recurrence include the following: A confir

Hepatitis B virus cellular immunity afte

Hepatitis B virus cellular immunity after liver transplantation: A role in preventing hepatitis B virus recurrence?

✍ Anne Marie Roque-Afonso 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB 👁 1 views

Chronic hepatitis B virus (HBV) infection is a common cause of advanced liver disease and hepatocellular carcinoma and has become a worldwide public health issue. Liver transplantation (LT) is the most effective therapeutic option for HBV-infected patients who have acute or chronic liver failure and

Antiviral treatment of recurrent hepatit

Antiviral treatment of recurrent hepatitis C after liver transplantation: The need for a multifaceted approach

✍ Didier Samuel 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB 👁 1 views

## H epatitis C virus (HCV)-related cirrhosis is currently the leading indication for liver transplantation in Europe and in the United States. 1,2 HCV recurrence after transplantation is almost universal, and 60%-90% of patients will develop lesions of chronic hepatitis C on the graft. 3 The cour

Hepatitis B immunoglobulin and/or nucleo

Hepatitis B immunoglobulin and/or nucleos(t)ide analogues for prophylaxis against hepatitis b virus recurrence after liver transplantation: A systematic review

✍ Evangelos Cholongitas; John Goulis; Evangelos Akriviadis; Geore V. Papatheodorid 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 395 KB

A combination of hepatitis B immunoglobulin (HBIG) and nucleos(t)ide analogues (NUCs) is currently recommended as prophylaxis against the recurrence of hepatitis B virus (HBV) after liver transplantation (LT), but the optimal protocol is a matter of controversy. The aim of this study was the identif

A randomized study comparing ribavirin a

A randomized study comparing ribavirin and interferon alfa monotherapy for hepatitis C recurrence after liver transplantation

✍ Edward J. Gane; Su-Kong Lo; Stephen M. Riordan; Bernard C. Portmann; Johnson Y. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 2 views

Hepatitis C virus (HCV) infection usually recurs after orthotopic liver transplantation (OLT), and most patients develop graft damage. This study compared the efficacy of interferon alfa (IFN-␣) and ribavirin monotherapies in liver transplant recipients with chronic hepatitis C in the graft. Thirty